Opens in a new tab

A Self-Guided Pathway for Functional Seizures

A five-session online programme reduced monthly functional-seizure frequency compared with standard care in a randomized Australian trial. It offers a possible way to extend structured support beyond specialist clinics.

November 10, 2026
Editorial
Digital support could shorten the gap between a functional-seizure diagnosis and structured care.PeopleImages / Shutterstock.com

IPM Take

Functional seizures often leave patients between neurology and psychological services. Re-PROGRAM suggests that a short, self-guided intervention can help after specialist diagnosis, but digital access only becomes meaningful when it sits inside a pathway that can monitor progress and respond when the programme is insufficient.

Executive Summary

The three-arm randomized trial enrolled 107 adults at a specialist Melbourne clinic; 96 contributed to the full analysis set. Participants had video-EEG-confirmed functional seizures and at least four seizures per month, and people with active comorbid epilepsy were excluded. The self-guided Re-PROGRAM intervention plus standard care reduced monthly seizure frequency compared with standard care alone across follow-up, with an overall rate ratio of 0.35. Anxiety also improved. The therapist-guided arm did not show a statistically significant seizure-frequency reduction against standard care, but the direct comparison of the two active formats was also not statistically significant.

Why it matters

  • Patients: A structured option could provide support sooner where specialist psychological appointments are scarce.
  • Clinicians: The programme requires a confirmed diagnosis, monitoring and a route to additional care when symptoms persist.
  • Payers: A scalable intervention is promising, but adoption should measure engagement, clinical outcomes and use of other services.
  • Digital-health developers: The trial demonstrates the value of testing a defined intervention against standard care rather than relying on usability claims.

The Re-PROGRAM randomized trial addresses a familiar gap in functional-seizure care. Patients may receive a specialist diagnosis but then wait for treatment that combines education, seizure-management strategies and psychological support. The online programme offered five structured sessions alongside standard care, either completed independently or with therapist guidance.

The self-guided arm had significantly lower reported monthly seizure frequency than standard care at six weeks, six months and 12 months, and showed sustained improvements in anxiety. That is encouraging for services with limited therapist capacity. It does not mean therapist support has been shown to be unnecessary: the therapist-guided arm was not significantly different from standard care on seizure frequency, while the direct comparison between the active arms was inconclusive.

Implementation should begin with the population studied. Participants had a video-EEG-confirmed diagnosis in a specialist service, and active epilepsy was excluded. A useful pathway would connect diagnosis, access to the programme, seizure and mental-health monitoring, and escalation for people who need more support. A digital intervention can extend a service’s reach, but it cannot carry the whole clinical pathway by itself.

Source & Evidence